Caroline A Walsh1, Caitriona Cahir2, Kathleen E Bennett2,3. 1. Division of Population Health Sciences, Beaux Lane House, Royal College of Surgeons in Ireland, Lower Mercer Street, Dublin 2, Ireland. carolinewalsh@rcsi.com. 2. Division of Population Health Sciences, Beaux Lane House, Royal College of Surgeons in Ireland, Lower Mercer Street, Dublin 2, Ireland. 3. Department of Pharmacology and Therapeutics, Trinity College Dublin, Trinity Health Centre for Health Sciences, St. James's Hospital, Dublin, Ireland.
Abstract
PURPOSE: To examine the association between antihypertensive medication (AHTM) implementation adherence and healthcare utilisation in community-dwelling adults aged ≥ 50 years in Ireland. METHODS: This was a prospective cohort study. The Irish Longitudinal Study on Ageing (TILDA) was linked to pharmacy claims data for participants aged ≥ 50 years. Participants were included if they had ≥ 3 pharmacy claims for one or more AHTM (ATC codes 'C02', 'C03', 'C07', 'C08' or 'C09') within the year preceding the year of self-reported healthcare utilisation outcome occurrence. Outcomes included self-reported general practitioner (GP), emergency department (ED), outpatient department visits and hospital admissions. Implementation adherence was measured using proportion of days covered (PDC), with participants classified as adherent if the average PDC ≥ 0.8. Negative binomial models were used to analyse the association between AHTM adherence and number of GP, ED, outpatient visits and hospitalisations (adjusted IRR and 95% CI are presented). RESULTS: One thousand four hundred thirty-one participants were included. The majority of participants (72.6%) were considered adherent. Good implementation adherence to AHTM was associated with a significant decrease in self-reported GP visits (adjusted IRR 0.91, 95% CI 0.83-0.99). Adherence had no significant impact on the number of ED visits, outpatient visits or hospitalisations reported by TILDA participants. CONCLUSIONS: Good adherence to AHTM was associated with less self-reported GP visits in this population, suggesting improved overall health status. However, the impact of medication non-adherence on the other self-reported healthcare utilisation outcomes (ED, outpatient visits and hospitalisations) was not evident in this study.
PURPOSE: To examine the association between antihypertensive medication (AHTM) implementation adherence and healthcare utilisation in community-dwelling adults aged ≥ 50 years in Ireland. METHODS: This was a prospective cohort study. The Irish Longitudinal Study on Ageing (TILDA) was linked to pharmacy claims data for participants aged ≥ 50 years. Participants were included if they had ≥ 3 pharmacy claims for one or more AHTM (ATC codes 'C02', 'C03', 'C07', 'C08' or 'C09') within the year preceding the year of self-reported healthcare utilisation outcome occurrence. Outcomes included self-reported general practitioner (GP), emergency department (ED), outpatient department visits and hospital admissions. Implementation adherence was measured using proportion of days covered (PDC), with participants classified as adherent if the average PDC ≥ 0.8. Negative binomial models were used to analyse the association between AHTM adherence and number of GP, ED, outpatient visits and hospitalisations (adjusted IRR and 95% CI are presented). RESULTS: One thousand four hundred thirty-one participants were included. The majority of participants (72.6%) were considered adherent. Good implementation adherence to AHTM was associated with a significant decrease in self-reported GP visits (adjusted IRR 0.91, 95% CI 0.83-0.99). Adherence had no significant impact on the number of ED visits, outpatient visits or hospitalisations reported by TILDAparticipants. CONCLUSIONS: Good adherence to AHTM was associated with less self-reported GP visits in this population, suggesting improved overall health status. However, the impact of medication non-adherence on the other self-reported healthcare utilisation outcomes (ED, outpatient visits and hospitalisations) was not evident in this study.
Entities:
Keywords:
Health outcomes; Hospitalisation; Medication adherence; Older
Authors: Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson Journal: BMJ Date: 2006-06-21
Authors: Shelly A Vik; David B Hogan; Scott B Patten; Jeffrey A Johnson; Lori Romonko-Slack; Colleen J Maxwell Journal: Drugs Aging Date: 2006 Impact factor: 3.923
Authors: Wanzhu Tu; Andrew B Morris; Jingjin Li; Jingwei Wu; James Young; D Craig Brater; Michael D Murray Journal: Clin Pharmacol Ther Date: 2005-03 Impact factor: 6.875
Authors: P Little; J Somerville; I Williamson; G Warner; M Moore; R Wiles; S George; A Smith; R Peveler Journal: Br J Gen Pract Date: 2001-12 Impact factor: 5.386
Authors: Eric K P Lee; Paul Poon; Benjamin H K Yip; Yacong Bo; Meng-Ting Zhu; Chun-Pong Yu; Alfonse C H Ngai; Martin C S Wong; Samuel Y S Wong Journal: J Am Heart Assoc Date: 2022-09-03 Impact factor: 6.106